Anti-TNF alpha therapy of rheumatoid arthritis: what have we learned?
about
Chemoprotection by phenolic antioxidantsHuman glutathione S-transferase P1-1 interacts with TRAF2 and regulates TRAF2-ASK1 signalsInflammatory cytokines induce production of CHI3L1 by articular chondrocytesCross-regulation of TNF and IFN-alpha in autoimmune diseasesTocilizumabA functional M196R polymorphism of tumour necrosis factor receptor type 2 is associated with systemic lupus erythematosus: a case-control study and a meta-analysisThe triterpenoid CDDO inhibits expression of matrix metalloproteinase-1, matrix metalloproteinase-13 and Bcl-3 in primary human chondrocytesApolipoprotein A-I infiltration in rheumatoid arthritis synovial tissue: a control mechanism of cytokine production?Interleukin-7 deficiency in rheumatoid arthritis.Anti-TNF-alpha antibody allows healing of joint damage in polyarthritic transgenic miceBiological basis for the use of botanicals in osteoarthritis and rheumatoid arthritis: a review.Flavonoids as Cytokine Modulators: A Possible Therapy for Inflammation-Related DiseasesCytokine-Defined B Cell Responses as Therapeutic Targets in Multiple SclerosisThe expanding role of immunopharmacology: IUPHAR Review 16Signal transduction inhibitors in treatment of myelodysplastic syndromesDrug delivery options to increase patient adherence and satisfaction in the management of rheumatoid arthritis -- focus on subcutaneous tocilizumabThe story of CD4+ CD28- T cells revisited: solved or still ongoing?Interactions between MSCs and immune cells: implications for bone healing.Lasker Clinical Medical Research Award. TNF defined as a therapeutic target for rheumatoid arthritis and other autoimmune diseasesRegulation and function of TPL-2, an IκB kinase-regulated MAP kinase kinase kinaseBikunin inhibits lipopolysaccharide-induced tumor necrosis factor alpha induction in macrophagesComparative persistence of the TNF antagonists in rheumatoid arthritis--a population-based cohort studyCombined anti-tumor necrosis factor-α therapy and DMARD therapy in rheumatoid arthritis patients reduces inflammatory gene expression in whole blood compared to DMARD therapy aloneTendons – time to revisit inflammationInterferon and granulopoiesis signatures in systemic lupus erythematosus bloodAsymptomatic infection with American cutaneous leishmaniasis: epidemiological and immunological studiesInsertion of foreign T cell epitopes in human tumor necrosis factor alpha with minimal effect on protein structure and biological activity.N-of-1 trials of expensive biological therapies: a third way?The co-expression of activating and inhibitory leukocyte immunoglobulin-like receptors in rheumatoid synovium.Immunomodulation of murine collagen-induced arthritis by N, N-dimethylglycine and a preparation of Perna canaliculusPatients with rheumatoid arthritis have an altered circulatory aggrecan profile.Elevated plasma level of HMGB1 is associated with disease activity and combined alterations with IFN-α and TNF-α in systemic lupus erythematosus.A variant of TNFR2-Fc fusion protein exhibits improved efficacy in treating experimental rheumatoid arthritis.Blood gene expression profiling in pediatric systemic lupus erythematosus and systemic juvenile idiopathic arthritis: from bench to bedside.The role of chemokines in Guillain-Barré syndrome.Fracture healing is accelerated in the absence of the adaptive immune system.OptCDR: a general computational method for the design of antibody complementarity determining regions for targeted epitope binding.Unchecked CD70 expression on T cells lowers threshold for T cell activation in rheumatoid arthritis.Molecular mechanism and therapeutic modulation of high mobility group box 1 release and action: an updated review.The Growing Need for Validated Biomarkers and Endpoints for Dry Eye Clinical Research
P2860
Q23919664-133B8D2A-028B-4A80-AADF-E4F666F1079DQ24320308-22D95B60-2D2C-4403-9E6F-FF3CA78EAAF5Q24338555-EB064AF6-E4E7-4193-ABDE-BC88E1DD3C52Q24556513-166EC3C9-A6C7-4EC4-9635-8FC64C9470F8Q24655317-B489D603-3411-43AE-A526-58851DA1F3F4Q24680313-44B7551F-C47B-4682-8A88-F42AE7DE23C1Q24797661-657A4D66-51EF-4D0A-9083-735DFE7DAA7EQ24798517-D43CF849-11AF-4EF9-9595-34A4D18E27B6Q24799450-217C2388-8738-490C-A796-ECDCB0125538Q24801075-237C29DE-63FE-4363-9C19-AB1B7D9BD227Q24816745-02436F87-1323-4568-87FA-BCDF73489CECQ26746303-E381915B-1992-4EFD-94AF-AD697A8D118FQ26771459-781B2FF1-9525-41F8-A260-A17A31FCB883Q26801862-CBD70ADD-FBCD-4CFA-AFDE-4AD69B9AC598Q26829903-CE3AD4D5-2440-4306-AF9D-366E10E1A77DQ27023091-43990EBC-9F99-4433-A76A-441E6CEB8B27Q28082856-8E51B229-E7FA-41BE-86E9-F99C324B6BB7Q28083741-E5B500CF-B942-443F-B7A8-EA20F67BF460Q28206018-AE733882-7BCA-4F18-997D-C2B2CE44B09AQ28392677-617108A5-613C-4C65-A87D-82D624F8EC5FQ28398007-CA3E9287-DF58-46A1-82EE-505C43DB6EE8Q28542423-373FA047-D6AE-4296-8882-AB5E755002D2Q28710288-DB6C7B15-3542-4C2E-A3DB-1AB9A1417A59Q29398484-F5454422-DE60-49C5-AB1D-3C77BACE89B3Q29615064-C830996C-67C6-4640-92A3-47CA6388D654Q30244323-CE3B387B-F3DE-4E11-B218-12A526DCE15AQ30341702-ABF400A3-EEB3-4B56-A2B1-ECE1EEC0DA4AQ30483827-4A2F6E5A-FCB1-4BCD-A365-6A49BFB53243Q30673087-6EC4E94B-8E25-43C5-B181-D3DA23CF8069Q33287342-3E154143-44DF-421E-A34D-DBC599ECA33AQ33338239-F2249DD7-434A-4321-86AE-B8D736379C16Q33393060-B209FCC8-89C9-4360-8246-E0F27DFD4076Q33530087-A91529C9-0F2A-41A4-B757-B9CC06FDF772Q33622723-39A3F6ED-319B-4A7E-8F84-91655828B5CDQ33624382-F69E2D70-25D0-44E6-A553-6E2A8AF6D4CCQ33635563-FB3BE872-3AB9-4E7C-8108-378228370101Q33694202-4E9BD0DA-1DA3-47B9-9FD2-048117879252Q33706812-28D1D1AB-0657-4833-99F3-9C6FC8FE34FAQ33751106-B5D636D0-43FD-4873-9B73-BDEA63713CA6Q33756582-86DEF186-BD42-42FE-A392-5E6B7C29DE4B
P2860
Anti-TNF alpha therapy of rheumatoid arthritis: what have we learned?
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Anti-TNF alpha therapy of rheumatoid arthritis: what have we learned?
@ast
Anti-TNF alpha therapy of rheumatoid arthritis: what have we learned?
@en
type
label
Anti-TNF alpha therapy of rheumatoid arthritis: what have we learned?
@ast
Anti-TNF alpha therapy of rheumatoid arthritis: what have we learned?
@en
prefLabel
Anti-TNF alpha therapy of rheumatoid arthritis: what have we learned?
@ast
Anti-TNF alpha therapy of rheumatoid arthritis: what have we learned?
@en
P1476
Anti-TNF alpha therapy of rheumatoid arthritis: what have we learned?
@en
P2093
P304
P356
10.1146/ANNUREV.IMMUNOL.19.1.163
P577
2001-01-01T00:00:00Z